Clinical Trial Update: Anlotinib Combined With Doxorubicin and Radiotherapy as Neoadjuvant Treatment for Soft Tissue Sarcoma [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating neoadjuvant therapy with Anlotinib combined with Doxorubicin and radiotherapy for soft tissue sarcoma; recruitment is ongoin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• Anlotinib (anlotinib)
• Doxorubicin (doxorubicin)

Snippet

Sponsor: Guangdong Provincial People's Hospital | Conditions: Soft Tissue Sarcoma, Doxorubicin | Phase 4 | Status: RECRUITING